Scientists find ‘mutant' gene behind foul-smelling species of wild ginger
With a smell of rotting flesh the flowers of certain species of wild ginger are unlikely to be used in a wedding bouquet – although they are irresistible to carrion-loving flies. Now researchers say they have worked out how the sulphurous scent is produced.
Scientists say the odour is down to small changes in an enzyme that prevents bad breath in humans.
'Some organisms have an extraordinary trait which is seemingly difficult to evolve, but such characteristics can evolve in a simpler manner than one would imagine,' said Dr Yudai Okuyama, the first author of the research from the National Museum of Nature and Science in Japan.
Writing in the journal Science, Okuyama and colleagues reported how they first investigated the origins of a key chemical known to be behind the sulfurous smell produced by some species of Asarum, or wild ginger.
This chemical, called dimethyl disulfide (DMDS), is thought to be produced from a substance called methanethiol. Methanethiol is known to cause bad breath in humans and is formed in plants and animals as the amino acid methionine is broken down.
The researchers confirmed this by feeding a form of methionine labelled with carbon-13 atoms to a species of wild ginger, A. fudsinoi, and found the DMDS released also contained carbon-13.
The team then looked at an array of different species of Asarum to identify genes whose activity varied with the amount of DMDS produced.
The work led to the identification of a gene that gives rise to a selenium-binding protein. Such proteins are found across the plant and animal kingdom, and typically convert methanethiol into less harmful substances. In humans this mechanism prevents halitosis.
The researchers found the 'normal' version of this gene was present in all of the plants and animals they considered, including the various species of Asarum. However, they found the latter also had a mutant form of the gene that produces a protein that turns methanethiol into DMDS. This mutant gene is more active in foul-smelling species.
The team said the change in function appeared to be down to a small number of mutations in the gene, with only two or three changes in the amino acids of the protein needed for the shift to occur.
Further work showed Eurya and Symplocarpus plants also have selenium-binding proteins that can turn methanethiol into DMDS, explaining why some species smell bad, with the team noting they appeared to have evolved independently.
However, not all foul-smelling plants produce their scent in the same way: the team found species of Amorphophallus – a group that includes a plant known as the 'corpse flower' – did not have a selenium-binding protein that converts methanethiol into DMDS.
'We think some similar enzyme that belong[s] to a different protein family might be responsible for the step,' said Okuyama.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
14 hours ago
- Wall Street Journal
RFK Jr.: HHS Moves to Restore Public Trust in Vaccines
Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning. Some would try to explain this away by blaming misinformation or antiscience attitudes. To do so, however, ignores a history of conflicts of interest, persecution of dissidents, a lack of curiosity, and skewed science that has plagued the vaccine regulatory apparatus for decades.


Fast Company
14 hours ago
- Fast Company
‘We dissent': NIH scientists sign letter criticizing Trump's cuts in public health research
In his confirmation hearings to lead the National Institutes of Health, Jay Bhattacharya pledged his openness to views that might conflict with his own. 'Dissent,' he said, 'is the very essence of science.' That commitment is being put to the test. On Monday, scores of scientists at the agency sent their Trump-appointed leader a letter titled the Bethesda Declaration, challenging 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' It says: 'We dissent.' In a capital where insiders often insist on anonymity to say such things publicly, 92 NIH researchers, program directors, branch chiefs and scientific review officers put their signatures on the letter — and their careers on the line. An additional 250 of their colleagues across the agency endorsed the declaration without using their names. The four-page letter, addressed to Bhattacharya, also was sent to Health Secretary Robert F. Kennedy Jr. and members of Congress who oversee the NIH. White House spokesman Kush Desai defended the administration's approach to federal research and said President Donald Trump is focused on restoring a 'Gold Standard' of science, not 'ideological activism.' Confronting a 'culture of fear' The signers went public in the face of a 'culture of fear and suppression' they say Trump's administration has spread through the federal civil service. 'We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources,' the declaration says. Bhattacharya responded to the declaration by saying it 'has some fundamental misconceptions about the policy directions the NIH has taken in recent months.' 'Nevertheless, respectful dissent in science is productive,' he said in a statement. 'We all want the NIH to succeed.' Named for the agency's headquarters location in Maryland, the Bethesda Declaration details upheaval in the world's premier public health research institution over the course of mere months. It addresses the termination of 2,100 research grants valued at more than $12 billion and some of the human costs that have resulted, such as cutting off medication regimens to participants in clinical trials or leaving them with unmonitored device implants. In one case, an NIH-supported study of multi-drug-resistant tuberculosis in Haiti had to be stopped, ceasing antibiotic treatment mid-course for patients. In a number of cases, trials that were mostly completed were rendered useless without the money to finish and analyze the work, the letter says. 'Ending a $5 million research study when it is 80% complete does not save $1 million,' it says, 'it wastes $4 million.' The mask comes off Jenna Norton, who oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases, recently appeared at a forum by Sen. Angela Alsobrooks, D-Md., to talk about what's happening at the NIH. At the event, she masked to conceal her identity. Now the mask is off. She was a lead organizer of the declaration. 'I want people to know how bad things are at NIH,' Norton told The Associated Press. The signers said they modeled their indictment after Bhattacharya's Great Barrington Declaration in 2020, when he was a professor at Stanford University Medical School. His declaration drew together likeminded infectious disease epidemiologists and public health scientists who dissented from what they saw as excessive COVID-19 lockdown policies and felt ostracized by the larger public health community that pushed those policies, including the NIH. 'He is proud of his statement, and we are proud of ours,' said Sarah Kobrin, a branch chief at the NIH's National Cancer Institute who signed the Bethesda Declaration. Cancer research is sidelined As chief of the Health Systems and Interventions Research Branch, Kobrin provides scientific oversight of researchers across the country who've been funded by the cancer institute or want to be. Cuts in personnel and money have shifted her work from improving cancer care research to what she sees as minimizing its destruction. 'So much of it is gone — my work,' she said. The 21-year NIH veteran said she signed because she didn't want to be 'a collaborator' in the political manipulation of biomedical science. Ian Morgan, a postdoctoral fellow with the National Institute of General Medical Sciences, also signed the declaration. 'We have a saying in basic science,' he said. 'You go and become a physician if you want to treat thousands of patients. You go and become a researcher if you want to save billions of patients. 'We are doing the research that is going to go and create the cures of the future,' he added. But that won't happen, he said, if Trump's Republican administration prevails with its searing grant cuts. The NIH employees interviewed by the AP emphasized they were speaking for themselves and not for their institutes nor the NIH. Dissenters range across the breadth of NIH Employees from all 27 NIH institutes and centers gave their support to the declaration. Most who signed are intimately involved with evaluating and overseeing extramural research grants. The letter asserts 'NIH trials are being halted without regard to participant safety' and the agency is shirking commitments to trial participants who 'braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health.' The Trump administration has gone at public health research on several fronts, both directly, as part of its broad effort to root out diversity, equity and inclusion values throughout the bureaucracy, and as part of its drive to starve some universities of federal money. At the White House, Desai said Americans 'have lost confidence in our increasingly politicized healthcare and research apparatus that has been obsessed with DEI and COVID, which the majority of Americans moved on from years ago.' A blunt ax swings This has forced 'indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' the declaration says. Some NIH employees have previously come forward in televised protests to air grievances, and many walked out of Bhattacharya's town hall with staff. The declaration is the first cohesive effort to register agency-wide dismay with the NIH's direction. The dissenters remind Bhattacharya in their letter of his oft-stated ethic that academic freedom must be a lynchpin in science. With that in place, he said in a statement in April, 'NIH scientists can be certain they are afforded the ability to engage in open, academic discourse as part of their official duties and in their personal capacities without risk of official interference, professional disadvantage or workplace retaliation.' Now it will be seen whether that's enough to protect those NIH employees challenging the Trump administration and him. 'There's a book I read to my kids, and it talks about how you can't be brave if you're not scared,' said Norton, who has three young children. 'I am so scared about doing this, but I am trying to be brave for my kids because it's only going to get harder to speak up.


Washington Post
a day ago
- Washington Post
NIH scientists go public to criticize Trump's deep cuts in public health research
WASHINGTON — In his confirmation hearings to lead the National Institutes of Health, Jay Bhattacharya pledged his openness to views that might conflict with his own. 'Dissent,' he said, 'is the very essence of science.' That commitment is being put to the test. On Monday, scores of scientists at the agency sent their Trump-appointed leader a letter titled the Bethesda Declaration, a frontal challenge to 'policies that undermine the NIH mission, waste public resources , and harm the health of Americans and people across the globe.'